Online meds

Recently added item(s)

dostinex 0.5 mg cabergoline


SKU: dostinex 0.5 mg Category:


dostinex 0.5 mg cabergoline

dostinex 0.5 mg cabergoline Tablets, for oral administration, contain 0.5 mg of cabergoline. Inactive
ingredients consist of leucine, USP, and lactose, NF.


The recommended dosage of DOSTINEX Tablets for initiation of therapy is 0.25 mg
twice a week. Dosage may be increased by 0.25 mg twice weekly up to a dosage of 1 mg
twice a week according to the patient’s serum prolactin level. Before initiating treatment,
cardiovascular evaluation should be performed and echocardiography should be
considered to assess for valvular disease.
Dosage increases should not occur more rapidly than every 4 weeks, so that the physician
can assess the patient’s response to each dosage level. If the patient does not respond
adequately, and no additional benefit is observed with higher doses, the lowest dose that
achieved maximal response should be used and other therapeutic approaches considered.
Patients receiving long term treatment with DOSTINEX should undergo periodic
assessment of their cardiac status and echocardiography should be considered.
After a normal serum prolactin level has been maintained for 6 months, DOSTINEX may
be discontinued, with periodic monitoring of the serum prolactin level to determine
whether or when treatment with DOSTINEX should be reinstituted. The durability of
efficacy beyond 24 months of therapy with DOSTINEX has not been established.


DOSTINEX Tablets are white, scored, capsule-shaped tablets containing 0.5 mg
cabergoline. Each tablet is scored on one side and has the letter P and the letter U on
either side of the breakline. The other side of the tablet is engraved with the number 700.


dostinex 0.5 mg


There are no reviews yet.

Be the first to review “dostinex 0.5 mg cabergoline”

Your email address will not be published. Required fields are marked *


Our  WhatsApp support team is here to answer your questions. Ask us anything!